Reality checkNow we're going to get institutional investment when no one is likely to buy the 25 cent public offering we have now? Who is going to invest in this dumpster fire when we have an unproven treatment that we may not even have the right to produce? The CEO say's the lawsuit is nonsense but there is a letter signed by Angus Jenkins stating that the late payment to Jed Wood would satisfy the condition precedent for the amended agreement giving Aspire the sole rights to ACP. I'm not a lawyer but that constitutes a big problem for anyone thinking of touching this. First it was January, then the end of February, then April then August, now "definitely this year." It's becoming clear that we can't get this phase 2 complete without data that Aspire is with holding. If that's the case, the company is finished. Aspire can likely drag out legal longer than we can and i'm pretty sure Peter Lacey can only float the costs for so long. Bottom line is either we can cobble together the phase 2 analysis without Aspire by years end as Smeenk claims or we're finished. And the way he dances around a concrete answer for the phase 2 completion, it really seems like more desperate stalling. I want to hope that we see a recovery and I'm waiting to see how this plays out but I fully expect to be diluted into oblivion before anything real happens with this company. Good luck fellas. We could really use some honesty from the company right now concerning how likely it is that we can complete the trial on our own but they will continue to paint you a nice picture until the truth can no longer be denied. And you guys can call me a basher all you like but the stock price should clue you in to what our chances really are here. FML what a disaster of an investment